Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

作者: Charles R. Swanepoel , Mohamed G. Atta , Vivette D. D’Agati , Michelle M. Estrella , Agnes B. Fogo

DOI: 10.1016/J.KINT.2017.11.007

关键词:

摘要: … of kidney disease and to treat end-stage kidney disease (… complex-mediated glomerular disease have been reported in … diagnosis, management, and prevention of kidney disease in this …

参考文章(156)
José A Perez-Molina, Rafael Rubio, Antonio Rivero, Juan Pasquau, Ignacio Suárez-Lozano, Melcior Riera, Miriam Estébanez, Jesús Santos, José Sanz-Moreno, Jesús Troya, Ana Mariño, Antonio Antela, Jordi Navarro, Herminia Esteban, Santiago Moreno, None, Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial Lancet Infectious Diseases. ,vol. 15, pp. 775- 784 ,(2015) , 10.1016/S1473-3099(15)00097-3
Sana Waheed, Ahmad Sakr, Neha D. Chheda, Gregory M. Lucas, Michelle Estrella, Derek M. Fine, Mohamed G. Atta, Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0129702
Ismail Yahaya, Olalekan A Uthman, Muhammed Mubashir B Uthman, Interventions for HIV-associated nephropathy. Cochrane Database of Systematic Reviews. ,(2013) , 10.1002/14651858.CD007183.PUB3
Patrick D. Dummer, Sophie Limou, Avi Z. Rosenberg, Jurgen Heymann, George Nelson, Cheryl A. Winkler, Jeffrey B. Kopp, APOL1 Kidney Disease Risk Variants: An Evolving Landscape Seminars in Nephrology. ,vol. 35, pp. 222- 236 ,(2015) , 10.1016/J.SEMNEPHROL.2015.04.008
Bhamidimarri Kalyan Ram, Czul Frank, Peyton Adam, Levy Cynthia, Hernandez Maria, Jeffers Lennox, Roth David, Schiff Eugene, Martin Paul, None, Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease Journal of Hepatology. ,vol. 63, pp. 763- 765 ,(2015) , 10.1016/J.JHEP.2015.06.004
G. J. Xu, T. Kula, Q. Xu, M. Z. Li, S. D. Vernon, T. Ndung'u, K. Ruxrungtham, J. Sanchez, C. Brander, R. T. Chung, K. C. O'Connor, B. Walker, H. B. Larman, S. J. Elledge, Comprehensive serological profiling of human populations using a synthetic human virome Science. ,vol. 348, pp. 0698- ,(2015) , 10.1126/SCIENCE.AAA0698
David Roth, David R Nelson, Annette Bruchfeld, AnnMarie Liapakis, Marcelo Silva, Howard Monsour, Paul Martin, Stanislas Pol, Maria-Carlota Londoño, Tarek Hassanein, Philippe J Zamor, Eli Zuckerman, Shuyan Wan, Beth Jackson, Bach-Yen Nguyen, Michael Robertson, Eliav Barr, Janice Wahl, Wayne Greaves, Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study The Lancet. ,vol. 386, pp. 1537- 1545 ,(2015) , 10.1016/S0140-6736(15)00349-9
JC Yombi, R Jones, A Pozniak, J-M Hougardy, FA Post, Monitoring of kidney function in HIV-positive patients. Hiv Medicine. ,vol. 16, pp. 457- 467 ,(2015) , 10.1111/HIV.12249
Vivette D. D'agati, Glen S. Markowitz, Velvie A. Pogue, Herman L. Anderson, Gerald B. Appel, Jen-Tse Cheng, Hepatitis C Virus-Associated Glomerular Disease in Patients with Human Immunodeficiency Virus Coinfection Journal of The American Society of Nephrology. ,vol. 10, pp. 1566- 1574 ,(1999) , 10.1681/ASN.V1071566
GM Lucas, A Cozzi-Lepri, CM Wyatt, FA Post, AM Bormann, NF Crum-Cianflone, MJ Ross, , Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. Hiv Medicine. ,vol. 15, pp. 116- 123 ,(2014) , 10.1111/HIV.12087